LUKE EVNIN - 12 Jun 2025 Form 4 Insider Report for Werewolf Therapeutics, Inc. (HOWL)

Role
Director
Signature
/s/ Jonathan Owen, Attorney-in-fact
Issuer symbol
HOWL
Transactions as of
12 Jun 2025
Net transactions value
$0
Form type
4
Filing time
13 Jun 2025, 16:10:08 UTC
Previous filing
30 Apr 2025
Next filing
29 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
EVNIN LUKE Director C/O WEREWOLF THERAPEUTICS, INC., 200 TALCOTT AVENUE, 2ND FLOOR, WATERTOWN /s/ Jonathan Owen, Attorney-in-fact 13 Jun 2025 0001134657

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HOWL Stock Option (right to buy) Award $0 +27,000 $0.000000 27,000 12 Jun 2025 Common Stock 27,000 $1.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on June 12, 2025. The shares underlying the option vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders following the grant date, subject to the reporting person's continued service as a director.